Category: vaccine

A healthcare worker administers…

A healthcare worker administers the coronavirus disease (COVID-19) vaccine to a pregnant woman, amidst the spread of the SARS-CoV-2 variant Omicron, in Johannesburg, South Africa, December 9, 2021. REUTERS/ Sumaya Hisham Unvaccinated people infected with the Omicron variant of coronavirus may be less prone to severe illness and requiring hospital…

Read More

AstraZeneca says third dose helps against Omicron

A test tube labelled with the Vaccine is seen in front of AstraZeneca logo in this illustration taken, September 9, 2020. REUTERS/Dado Ruvic/Illustration AstraZeneca said on Thursday that preliminary data from a trial showed that its COVID-19 shot, Vaxzevria, generated an increase in antibodies against the Omicron and other variants…

Read More

Omicron May Infect Half of Europeans Within Weeks, WHO Says

Image Credit:CIPhotos via Getty Images  More than half of Europe’s population could become infected with omicron within weeks at current transmission speeds, a World Health Organization official said. The fast-spreading variant represents a “west-to-east tsunami sweeping  the region,” Hans Kluge, WHO regional director  for Europe, said in a briefing Tuesday. …

Read More

MODERNA CEO SAYS PEOPLE MAY NEED ANOTHER BOOSTER IN FALL OF 2022

A pharmacist holds a vial of the Moderna coronavirus disease (COVID-19) vaccine in West Haven, Connecticut, U.S., February 17, 2021. REUTERS/Mike Segar The effectiveness of COVID-19 boosters  is likely to wane in the coming months, and people may need another shot in the fall of 2022, Moderna Inc CEO Stéphane…

Read More

French parliament approves Macron’s vaccine pass

  People wearing protective face masks walk in the Tuileries Gardens in Paris amid the coronavirus disease (COVID-19) outbreak in France, January 5, 2022. REUTERS/Gonzalo Fuentes The French parliament on Thursday approved President Emmanuel Macron’s plans for a vaccination card to  curb the spread of the Omicron variant after Macron…

Read More

Pfizer, BioNTech to jointly develop shingles vaccine

Pfizer headquarters in New York. Getty Images Pfizer and Germany’s BioNTech announced on Wednesday that they would develop a potential mRNA-based vaccine for the prevention of viral  shingles, working together for the third time after the success of their COVID-19 vaccine.  Pfizer partnered with BioNTech in 2018 for an influenza…

Read More